Voyxact

Active Ingredient(s): Sibeprenlimab-szsi
FDA Approved: * November 25, 2025
Pharm Company: * OTSUKA PHARM CO LTD
Category: Immune System
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Voyxact 200 mg/ml Subcutaneous Injection
NDC: 59148-400
Labeler:
Otsuka America Pharmaceutical, Inc.